New drug "expected to hit the market within 2 years", page-47

Hi @dyeman , we should hear some news from DMX-200 FSGS CKD 2B trial soon (as to progress). This is our FDA Orphan status trial.

As you know, I’m really excited to hear news...I topped up 23k shares today, still waiting on 4K to be filled at 0.13c. We appear to be flying under the radar as usual on the ASX...I saw today as an opportunity. I took it by the horns.

The Diabetes CKD trial: I think this won’t happen until late 2018 early 2019, Kathy has indicated that, unless we get a Pharma Deal or Partnership sooner. It will be beneficial to be a much larger trial for diabetes, I’m sure we’ll get there mate. . Massive supporter as always for DXB. xo